AFFINIA THERAPEUTICS
Live / Applied — Final refusal mailed (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 30 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98383243
- Mark type
- Stylized text
- Filed
- 30 Jan 2024
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceutical injectables and preparations, namely, vectors and preparations for gene therapy; provision of scientific research information in the field of adeno-associated virus (AAV) vectors and preparations for gene therapy; pharmaceutical engineering services, namely, pharmaceutical products development of vectors and gene therapy pharmaceutical preparations; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells
Owner
- Affinia Therapeutics Inc., Waltham, MA, US
Prosecution history
- 28 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 28 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 29 Oct 2025 — FINAL REFUSAL E-MAILED
- 29 Oct 2025 — FINAL REFUSAL WRITTEN
- 13 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jun 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 11 Jun 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 11 Jun 2025 — LETTER OF SUSPENSION E-MAILED
- 11 Jun 2025 — SUSPENSION LETTER WRITTEN
- 12 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 May 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 11 Mar 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED